nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—BCHE—Cisplatin—testicular cancer	0.411	0.578	CbGbCtD
Pyridostigmine—CYP3A4—Ifosfamide—testicular cancer	0.128	0.181	CbGbCtD
Pyridostigmine—CYP3A4—Vinblastine—testicular cancer	0.0681	0.0959	CbGbCtD
Pyridostigmine—CYP3A4—Etoposide—testicular cancer	0.0614	0.0864	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—testicular cancer	0.0419	0.0589	CbGbCtD
Pyridostigmine—Chest discomfort—Etoposide—testicular cancer	0.0032	0.0111	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Ifosfamide—testicular cancer	0.00319	0.011	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Ifosfamide—testicular cancer	0.00301	0.0104	CcSEcCtD
Pyridostigmine—Lethargy—Dactinomycin—testicular cancer	0.0029	0.01	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—testicular cancer	0.0027	0.00932	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—testicular cancer	0.0025	0.00862	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Vinblastine—testicular cancer	0.00248	0.00857	CcSEcCtD
Pyridostigmine—Cardiac arrest—Ifosfamide—testicular cancer	0.00248	0.00855	CcSEcCtD
Pyridostigmine—Alopecia—Chlorambucil—testicular cancer	0.00241	0.00831	CcSEcCtD
Pyridostigmine—Alopecia—Vinblastine—testicular cancer	0.00221	0.00761	CcSEcCtD
Pyridostigmine—Agitation—Chlorambucil—testicular cancer	0.00218	0.00752	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Bleomycin—testicular cancer	0.0021	0.00724	CcSEcCtD
Pyridostigmine—Pollakiuria—Ifosfamide—testicular cancer	0.00208	0.00718	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—testicular cancer	0.00206	0.0071	CcSEcCtD
Pyridostigmine—Convulsion—Chlorambucil—testicular cancer	0.00205	0.00709	CcSEcCtD
Pyridostigmine—Cramp muscle—Cisplatin—testicular cancer	0.00202	0.00698	CcSEcCtD
Pyridostigmine—Cardiac arrest—Etoposide—testicular cancer	0.00196	0.00675	CcSEcCtD
Pyridostigmine—Vertigo—Vinblastine—testicular cancer	0.00195	0.00674	CcSEcCtD
Pyridostigmine—Confusional state—Chlorambucil—testicular cancer	0.00195	0.00673	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—testicular cancer	0.0019	0.00657	CcSEcCtD
Pyridostigmine—Musculoskeletal stiffness—Methotrexate—testicular cancer	0.00189	0.00653	CcSEcCtD
Pyridostigmine—Sweating increased—Cisplatin—testicular cancer	0.00189	0.00652	CcSEcCtD
Pyridostigmine—Convulsion—Vinblastine—testicular cancer	0.00188	0.0065	CcSEcCtD
Pyridostigmine—Alopecia—Bleomycin—testicular cancer	0.00186	0.00643	CcSEcCtD
Pyridostigmine—Cramp muscle—Etoposide—testicular cancer	0.00185	0.00639	CcSEcCtD
Pyridostigmine—Bradycardia—Ifosfamide—testicular cancer	0.00183	0.00633	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—testicular cancer	0.00174	0.00599	CcSEcCtD
Pyridostigmine—Sweating increased—Etoposide—testicular cancer	0.00173	0.00598	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—testicular cancer	0.00172	0.00595	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—testicular cancer	0.00161	0.00555	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—testicular cancer	0.00159	0.0055	CcSEcCtD
Pyridostigmine—Feeling abnormal—Chlorambucil—testicular cancer	0.00159	0.0055	CcSEcCtD
Pyridostigmine—Paraesthesia—Vinblastine—testicular cancer	0.00159	0.00549	CcSEcCtD
Pyridostigmine—Alopecia—Ifosfamide—testicular cancer	0.00159	0.00549	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00158	0.00546	CcSEcCtD
Pyridostigmine—Bradycardia—Cisplatin—testicular cancer	0.00158	0.00546	CcSEcCtD
Pyridostigmine—Myalgia—Bleomycin—testicular cancer	0.00156	0.00539	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—testicular cancer	0.00154	0.00532	CcSEcCtD
Pyridostigmine—Urticaria—Chlorambucil—testicular cancer	0.00154	0.0053	CcSEcCtD
Pyridostigmine—Abdominal pain—Chlorambucil—testicular cancer	0.00153	0.00528	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Methotrexate—testicular cancer	0.00151	0.00521	CcSEcCtD
Pyridostigmine—Confusional state—Bleomycin—testicular cancer	0.00151	0.00521	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—testicular cancer	0.00149	0.00513	CcSEcCtD
Pyridostigmine—Feeling abnormal—Vinblastine—testicular cancer	0.00146	0.00504	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—testicular cancer	0.00146	0.00503	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00145	0.005	CcSEcCtD
Pyridostigmine—Agitation—Ifosfamide—testicular cancer	0.00144	0.00497	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—testicular cancer	0.00143	0.00493	CcSEcCtD
Pyridostigmine—Hypersensitivity—Chlorambucil—testicular cancer	0.00143	0.00492	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Methotrexate—testicular cancer	0.00142	0.00491	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Etoposide—testicular cancer	0.00142	0.00489	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—testicular cancer	0.00141	0.00488	CcSEcCtD
Pyridostigmine—Vertigo—Ifosfamide—testicular cancer	0.00141	0.00486	CcSEcCtD
Pyridostigmine—Abdominal pain—Vinblastine—testicular cancer	0.0014	0.00484	CcSEcCtD
Pyridostigmine—Hypotension—Bleomycin—testicular cancer	0.0014	0.00483	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—testicular cancer	0.00139	0.0048	CcSEcCtD
Pyridostigmine—Asthenia—Chlorambucil—testicular cancer	0.00139	0.00479	CcSEcCtD
Pyridostigmine—Alopecia—Cisplatin—testicular cancer	0.00137	0.00474	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00136	0.00471	CcSEcCtD
Pyridostigmine—Convulsion—Ifosfamide—testicular cancer	0.00136	0.00469	CcSEcCtD
Pyridostigmine—Paraesthesia—Bleomycin—testicular cancer	0.00134	0.00464	CcSEcCtD
Pyridostigmine—Myalgia—Ifosfamide—testicular cancer	0.00133	0.00461	CcSEcCtD
Pyridostigmine—Flatulence—Cisplatin—testicular cancer	0.00133	0.0046	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—testicular cancer	0.00133	0.0046	CcSEcCtD
Pyridostigmine—Diarrhoea—Chlorambucil—testicular cancer	0.00132	0.00457	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—testicular cancer	0.00131	0.00451	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vinblastine—testicular cancer	0.00131	0.00451	CcSEcCtD
Pyridostigmine—Muscle spasms—Cisplatin—testicular cancer	0.0013	0.00449	CcSEcCtD
Pyridostigmine—Confusional state—Ifosfamide—testicular cancer	0.00129	0.00445	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—testicular cancer	0.00129	0.00445	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—testicular cancer	0.00128	0.00441	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00127	0.00439	CcSEcCtD
Pyridostigmine—Asthenia—Vinblastine—testicular cancer	0.00127	0.00439	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—testicular cancer	0.00126	0.00434	CcSEcCtD
Pyridostigmine—Lethargy—Methotrexate—testicular cancer	0.00126	0.00434	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00124	0.00427	CcSEcCtD
Pyridostigmine—Feeling abnormal—Bleomycin—testicular cancer	0.00123	0.00426	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—testicular cancer	0.00123	0.00425	CcSEcCtD
Pyridostigmine—Vomiting—Chlorambucil—testicular cancer	0.00123	0.00425	CcSEcCtD
Pyridostigmine—Diarrhoea—Vinblastine—testicular cancer	0.00121	0.00419	CcSEcCtD
Pyridostigmine—Hypotension—Ifosfamide—testicular cancer	0.0012	0.00413	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—testicular cancer	0.00119	0.00411	CcSEcCtD
Pyridostigmine—Urticaria—Bleomycin—testicular cancer	0.00119	0.00411	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—testicular cancer	0.00118	0.00408	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—testicular cancer	0.00118	0.00406	CcSEcCtD
Pyridostigmine—Convulsion—Cisplatin—testicular cancer	0.00117	0.00404	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00117	0.00402	CcSEcCtD
Pyridostigmine—Myalgia—Cisplatin—testicular cancer	0.00115	0.00397	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—testicular cancer	0.00115	0.00397	CcSEcCtD
Pyridostigmine—Nausea—Chlorambucil—testicular cancer	0.00115	0.00397	CcSEcCtD
Pyridostigmine—Paraesthesia—Ifosfamide—testicular cancer	0.00115	0.00397	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00114	0.00394	CcSEcCtD
Pyridostigmine—Somnolence—Ifosfamide—testicular cancer	0.00114	0.00393	CcSEcCtD
Pyridostigmine—Vomiting—Vinblastine—testicular cancer	0.00113	0.00389	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—testicular cancer	0.00111	0.00384	CcSEcCtD
Pyridostigmine—Headache—Vinblastine—testicular cancer	0.00111	0.00383	CcSEcCtD
Pyridostigmine—Abdominal pain—Dactinomycin—testicular cancer	0.0011	0.00381	CcSEcCtD
Pyridostigmine—Hypersensitivity—Bleomycin—testicular cancer	0.0011	0.00381	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—testicular cancer	0.0011	0.00378	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—testicular cancer	0.00109	0.00376	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—testicular cancer	0.00109	0.00376	CcSEcCtD
Pyridostigmine—Asthenia—Bleomycin—testicular cancer	0.00107	0.00371	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—testicular cancer	0.00107	0.0037	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Cisplatin—testicular cancer	0.00107	0.00368	CcSEcCtD
Pyridostigmine—Asthma—Methotrexate—testicular cancer	0.00106	0.00367	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—testicular cancer	0.00106	0.00365	CcSEcCtD
Pyridostigmine—Feeling abnormal—Ifosfamide—testicular cancer	0.00105	0.00364	CcSEcCtD
Pyridostigmine—Nausea—Vinblastine—testicular cancer	0.00105	0.00363	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00105	0.00361	CcSEcCtD
Pyridostigmine—Hypotension—Cisplatin—testicular cancer	0.00103	0.00356	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—testicular cancer	0.00103	0.00355	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—testicular cancer	0.00102	0.00352	CcSEcCtD
Pyridostigmine—Urticaria—Ifosfamide—testicular cancer	0.00102	0.00351	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—testicular cancer	0.00101	0.0035	CcSEcCtD
Pyridostigmine—Abdominal pain—Ifosfamide—testicular cancer	0.00101	0.00349	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00101	0.00347	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—testicular cancer	0.001	0.00346	CcSEcCtD
Pyridostigmine—Asthenia—Dactinomycin—testicular cancer	0.001	0.00346	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—testicular cancer	0.000996	0.00344	CcSEcCtD
Pyridostigmine—Paraesthesia—Cisplatin—testicular cancer	0.000991	0.00342	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—testicular cancer	0.000978	0.00337	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—testicular cancer	0.000977	0.00337	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—testicular cancer	0.000958	0.00331	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—testicular cancer	0.000955	0.0033	CcSEcCtD
Pyridostigmine—Vomiting—Bleomycin—testicular cancer	0.000952	0.00329	CcSEcCtD
Pyridostigmine—Drowsiness—Methotrexate—testicular cancer	0.000949	0.00328	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—testicular cancer	0.000944	0.00326	CcSEcCtD
Pyridostigmine—Rash—Bleomycin—testicular cancer	0.000944	0.00326	CcSEcCtD
Pyridostigmine—Dermatitis—Bleomycin—testicular cancer	0.000943	0.00326	CcSEcCtD
Pyridostigmine—Hypersensitivity—Ifosfamide—testicular cancer	0.000943	0.00325	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—testicular cancer	0.000928	0.0032	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—testicular cancer	0.000922	0.00318	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—testicular cancer	0.00092	0.00318	CcSEcCtD
Pyridostigmine—Asthenia—Ifosfamide—testicular cancer	0.000918	0.00317	CcSEcCtD
Pyridostigmine—Feeling abnormal—Cisplatin—testicular cancer	0.000909	0.00314	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—testicular cancer	0.000908	0.00313	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—testicular cancer	0.000899	0.0031	CcSEcCtD
Pyridostigmine—Epistaxis—Methotrexate—testicular cancer	0.000895	0.00309	CcSEcCtD
Pyridostigmine—Nausea—Bleomycin—testicular cancer	0.000889	0.00307	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—testicular cancer	0.000888	0.00307	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—testicular cancer	0.000888	0.00306	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—testicular cancer	0.000887	0.00306	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—testicular cancer	0.000881	0.00304	CcSEcCtD
Pyridostigmine—Diarrhoea—Ifosfamide—testicular cancer	0.000876	0.00302	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—testicular cancer	0.000852	0.00294	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—testicular cancer	0.000838	0.00289	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—testicular cancer	0.000833	0.00287	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—testicular cancer	0.000829	0.00286	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—testicular cancer	0.000826	0.00285	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—testicular cancer	0.000822	0.00284	CcSEcCtD
Pyridostigmine—Vomiting—Ifosfamide—testicular cancer	0.000814	0.00281	CcSEcCtD
Pyridostigmine—Hypersensitivity—Cisplatin—testicular cancer	0.000813	0.00281	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—testicular cancer	0.000812	0.0028	CcSEcCtD
Pyridostigmine—Rash—Ifosfamide—testicular cancer	0.000807	0.00278	CcSEcCtD
Pyridostigmine—Dermatitis—Ifosfamide—testicular cancer	0.000806	0.00278	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—testicular cancer	0.000803	0.00277	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—testicular cancer	0.000799	0.00276	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—testicular cancer	0.000793	0.00274	CcSEcCtD
Pyridostigmine—Asthenia—Cisplatin—testicular cancer	0.000792	0.00273	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—testicular cancer	0.000775	0.00268	CcSEcCtD
Pyridostigmine—Nausea—Ifosfamide—testicular cancer	0.00076	0.00262	CcSEcCtD
Pyridostigmine—Diarrhoea—Cisplatin—testicular cancer	0.000755	0.00261	CcSEcCtD
Pyridostigmine—Alopecia—Methotrexate—testicular cancer	0.000753	0.0026	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—testicular cancer	0.000751	0.00259	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—testicular cancer	0.000745	0.00257	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000734	0.00253	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—testicular cancer	0.000725	0.0025	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—testicular cancer	0.000705	0.00243	CcSEcCtD
Pyridostigmine—Vomiting—Cisplatin—testicular cancer	0.000701	0.00242	CcSEcCtD
Pyridostigmine—Rash—Cisplatin—testicular cancer	0.000696	0.0024	CcSEcCtD
Pyridostigmine—Dermatitis—Cisplatin—testicular cancer	0.000695	0.0024	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—testicular cancer	0.000692	0.00239	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—testicular cancer	0.000684	0.00236	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—testicular cancer	0.000667	0.0023	CcSEcCtD
Pyridostigmine—Vertigo—Methotrexate—testicular cancer	0.000666	0.0023	CcSEcCtD
Pyridostigmine—Nausea—Cisplatin—testicular cancer	0.000655	0.00226	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—testicular cancer	0.000652	0.00225	CcSEcCtD
Pyridostigmine—Convulsion—Methotrexate—testicular cancer	0.000643	0.00222	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—testicular cancer	0.000643	0.00222	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—testicular cancer	0.000638	0.0022	CcSEcCtD
Pyridostigmine—Rash—Etoposide—testicular cancer	0.000637	0.0022	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—testicular cancer	0.000637	0.0022	CcSEcCtD
Pyridostigmine—Headache—Etoposide—testicular cancer	0.000633	0.00219	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—testicular cancer	0.000633	0.00218	CcSEcCtD
Pyridostigmine—Myalgia—Methotrexate—testicular cancer	0.000632	0.00218	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—testicular cancer	0.000624	0.00215	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—testicular cancer	0.000618	0.00213	CcSEcCtD
Pyridostigmine—Confusional state—Methotrexate—testicular cancer	0.00061	0.00211	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—testicular cancer	0.00061	0.00211	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—testicular cancer	0.000601	0.00208	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—testicular cancer	0.0006	0.00207	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—testicular cancer	0.000591	0.00204	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—testicular cancer	0.00059	0.00204	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Methotrexate—testicular cancer	0.000585	0.00202	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—testicular cancer	0.000577	0.00199	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—testicular cancer	0.000571	0.00197	CcSEcCtD
Pyridostigmine—Hypotension—Methotrexate—testicular cancer	0.000566	0.00195	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—testicular cancer	0.000565	0.00195	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—testicular cancer	0.000557	0.00192	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000552	0.0019	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—testicular cancer	0.000548	0.00189	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—testicular cancer	0.000547	0.00189	CcSEcCtD
Pyridostigmine—Paraesthesia—Methotrexate—testicular cancer	0.000544	0.00188	CcSEcCtD
Pyridostigmine—Somnolence—Methotrexate—testicular cancer	0.000538	0.00186	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—testicular cancer	0.000529	0.00183	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—testicular cancer	0.000529	0.00182	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000516	0.00178	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—testicular cancer	0.000509	0.00176	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000507	0.00175	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—testicular cancer	0.000504	0.00174	CcSEcCtD
Pyridostigmine—Feeling abnormal—Methotrexate—testicular cancer	0.000499	0.00172	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000495	0.00171	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—testicular cancer	0.00049	0.00169	CcSEcCtD
Pyridostigmine—Urticaria—Methotrexate—testicular cancer	0.000481	0.00166	CcSEcCtD
Pyridostigmine—Abdominal pain—Methotrexate—testicular cancer	0.000479	0.00165	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000478	0.00165	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—testicular cancer	0.000471	0.00162	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—testicular cancer	0.000467	0.00161	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—testicular cancer	0.000466	0.00161	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000463	0.0016	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—testicular cancer	0.00045	0.00155	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—testicular cancer	0.000448	0.00155	CcSEcCtD
Pyridostigmine—Hypersensitivity—Methotrexate—testicular cancer	0.000446	0.00154	CcSEcCtD
Pyridostigmine—Asthenia—Methotrexate—testicular cancer	0.000434	0.0015	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—testicular cancer	0.000432	0.00149	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000429	0.00148	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—testicular cancer	0.000417	0.00144	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—testicular cancer	0.000416	0.00144	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—testicular cancer	0.000414	0.00143	CcSEcCtD
Pyridostigmine—Diarrhoea—Methotrexate—testicular cancer	0.000414	0.00143	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—testicular cancer	0.000406	0.0014	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—testicular cancer	0.000388	0.00134	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—testicular cancer	0.000386	0.00133	CcSEcCtD
Pyridostigmine—Vomiting—Methotrexate—testicular cancer	0.000385	0.00133	CcSEcCtD
Pyridostigmine—Rash—Methotrexate—testicular cancer	0.000382	0.00132	CcSEcCtD
Pyridostigmine—Dermatitis—Methotrexate—testicular cancer	0.000381	0.00132	CcSEcCtD
Pyridostigmine—Headache—Methotrexate—testicular cancer	0.000379	0.00131	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—testicular cancer	0.000376	0.0013	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—testicular cancer	0.00036	0.00124	CcSEcCtD
Pyridostigmine—Nausea—Methotrexate—testicular cancer	0.00036	0.00124	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—testicular cancer	0.000359	0.00124	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—testicular cancer	0.000357	0.00123	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—testicular cancer	0.000357	0.00123	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—testicular cancer	0.000355	0.00123	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—testicular cancer	0.000337	0.00116	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—testicular cancer	0.000333	0.00115	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—testicular cancer	0.000331	0.00114	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—testicular cancer	0.00033	0.00114	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—testicular cancer	0.000328	0.00113	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—testicular cancer	0.000311	0.00107	CcSEcCtD
